... Colchicine Inflammation Myocardial infarction Stroke Coronary revascularization See the editorial comment for this article ‘Colchicine in secondary prevention: making sense out of diversity’, by S.J. Pocock and G. Mendieta, https://doi.org/10.1093/eurheartj/ehaf266 . Patients diagnosed...

... Model ( https://dbpia.nl.go.kr/pages/standard-publication-reuse-rights ) Abstract Background and Aims Identification of patients with acute coronary syndrome requiring coronary revascularization can be challenging due to inconclusive electrocardiogram (ECG) findings or biomarker results. A deep...

... (hibernating) myocardial segments that can regain function after coronary revascularization. Various imaging techniques, including positron emission tomography (PET) with retention tracers like ⁸²Rb, have shown equivocal results. However, recent randomized studies have found limited value...

... composition, control arm, length of follow-up, number of participants in each arm, use of statins, outcomes definition, and number of events in the intervention and control arms. The main outcome was coronary revascularization, reported as PCI and/or CABG; secondary outcomes were major cardiovascular events...

... vessel disease Bifurcation lesion Coronary stenosis Coronary revascularization Despite technical and technological advancements, true coronary bifurcation lesions (CBL) remain one of the most complex yet common scenarios in percutaneous coronary interventions (PCI), accounting for up to 20...

... dysfunction in industrialized countries. The pathophysiological substrate of hibernating myocardium constitutes the conceptual target of coronary revascularization by coronary artery bypass graft (CABG) or coronary angioplasty or percutaneous coronary intervention (PCI). Studies, mainly observational...

...Giuseppe Patti; Chiara Ghiglieno Early coronary revascularization is a first choice therapeutic strategy for acute STEMI. Despite early coronary angioplasty, however, in some cases, there is a lower efficacy of revascularization, with less favourable clinical outcome, both in the short and long...

..., coronary revascularization recommendations in patients undergoing TAVI are unclear, since randomized controlled trials are lacking. ² We present a case of a patient with severe AS and concomitant CAD to illustrate the presentation and management of such a patient, highlighting the current...

... Anticoagulant Coronary revascularization Globally, the population is ageing, with older people becoming a proportionally larger share of the total population. ^{1 , 2} In Europe in 2017, more than 20% of the population was age ≥60 years, and this is projected to increase to 35% by 2050. The incidence...

... myocardial infarction Coronary revascularization Myocardial injury We then aimed to determine the impact of the various definitions on MACE-free survival. Mid-term results after CABG were obtained by including data for a median follow-up of 3.8 years (interquartile range: 2.1–5.7 years). Patients with pMI...

... with stable CAD who underwent [¹⁵O]H₂O PET perfusion imaging at baseline and after clinically driven percutaneous or surgical coronary revascularization between 2012 and 2019. The clinical indication for revascularization was based on angina, evaluation of ischaemia, viability testing...

... of recurrent CP in patients with new-onset SAP. Graphical Abstract Graphical Abstract stable angina pectoris coronary computed tomography angiography FFR_CT coronary revascularization chest pain Large-scale studies of patients with stable angina pectoris (SAP) have not shown any reduction...

... Although current guidelines recommend non-invasive cardiac imaging in patients with suspected CAD, ² the impact of non-invasive imaging strategies to guide initial coronary revascularization is still controversial. Although the ISCHEMIA trial highlighted the pivotal role of optimized medical...

.... Graphical Abstract Graphical Abstract Recurrent and Total Cardiovascular Events in the ISCHEMIA Trial. Chronic ischaemic heart disease Coronary revascularization Optimal medical therapy Stable angina See the editorial comment for this article ‘First and Recurrent Events in the ISCHEMIA trial: Two...

... during acute HF hospitalization with 2-year mortality, cardiovascular death, HF readmissions, and coronary revascularization. Methods and results  In a two-stage sampling process, we identified acute HF patients who presented to 70 emergency departments in Ontario (April 2010 to March 2013...

...-specific measures ( Figure 1 ). Historically, PRO outcomes used in coronary revascularization trials have been heterogeneous, due to inconsistency in the primary outcome measures used. For example, in the Synergy between PCI with Taxus and Cardiac Surgery (SYNTAX) trial, ⁶ QOL...

..., in-stent restenosis. Acute coronary syndromes Chronic coronary syndromes Myocardial infarction Coronavirus disease 19 Clinical practice guidelines Drug-eluting stents Drug-coated balloons Antiplatelet drugs Coronary revascularization Stent thrombosis Left main coronary artery In-stent restenosis...

... 80 mmHg with peripheral signs of hypoperfusion. Because of low urinary output and signs of volume overload, renal replacement therapy was initiated with continuous venovenous haemodiafiltration. Cardiogenic shock Coronary revascularization Haemodynamic support Case report Learning points...

... not receive IVIG until day 21 of his illness. Patients with Kawasaki disease complicated by significant aneurysms will often require coronary revascularization due to vessel wall changes both within the aneurysm and the adjoining area. There are no randomized controlled trials of coronary artery bypass...

.... After adjustments for socio-demographic factors and sick-leave days in the 12 months before revascularization, HR remained high in all patients with diabetes mellitus regardless of type of revascularization. Conclusions DP after coronary revascularization was common, especially among women and CABG...